The Relationship between Glycemic Control and Plasma Vascular Endothelial Growth Factor and Endothelin-1 Concentration in Diabetic Patients

Metabolism: Clinical and Experimental

Volumn 53, Issue 5, 2004, Pages 550-555

  Kakizawa, Hiroaki ^b   Itoh, Mitsuyasu ^a   Itoh, Yasutoshi ^b   Imamura, Shigeo ^b   Ishiwata, Yoko ^b   Matsumoto, Takashi ^b   Yamamoto, Keiko ^b   Kato, Taiya ^b   Ono, Yasunaga ^b   Nagata, Mutsuko ^b   Hayakawa, Nobuki ^b   Suzuki, Atsushi ^b   Goto, Yoshie ^b   Oda, Naohisa ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENDOTHELIN 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME IMMUNOASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 2342519443     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.12.002     Document Type: Article

References (35)

1. Eastman RC, Javitt JC, Herman WH, et al: Prevention strategies for type 2 diabetes mellitus-A health and economic perspective, in LeRoith D, Taylor SI, Olefsky JM, (eds): Diabetes Mellitus-A Fundamental and Clinical Text. ed 2. Philadelphia, PA, Lippincott Williams & Wilkins, 2000, pp 746-757
2. Hopfner RL, Gopalakrishnan V: Endothelin: Emerging role in diabetic vascular complications. Diabetologia 42:1383-1394, 1999
3. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 58:S113-119, 2000 (suppl 77)
4. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 317:713-720, 1998
5. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989
6. Shibuya M: Structure and function of VEGFNEGF-receptor system involved in angiogenesis. Cell Struct Funct 26:25-35, 2001
7. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
8. Adamis AP, Miller JW, Bernal MT, et al: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450, 1994
9. Tolentino MJ, Miller JW, Gragoudas ES, et al: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820-1828, 1996
10. Tolentino MJ, Miller JW, Gragoudas ES, et al: Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114:964-970, 1996
11. Amin RH, Frank RN, Kennedy A, et al: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47, 1997
12. Brausewetter F, Jehle PM, Jung MF, et al: Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Horm Metab Res 33:713-720, 2001
13. Santilli F, Spagnoli A, Mohn A, et al: Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type I diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 86:3871-3876, 2001
14. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
15. Masaki T: Possible role of endothelin in endothelial regulation of vascular tone. Ann Rev Pharmacol Toxicol 35:235-255, 1995
16. Yanagisawa M, Masaki T: Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10:374-378, 1989
17. Sakurai T, Yanagisawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108, 1992
18. Mather KJ, Mirzamohammadi B, Lteif A, et al: Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 51:3517-3523, 2002
19. Sawamura T, Kimura S, Shinmi O, et al: Analysis of endothelin related peptides in culture supernatant of porcine aortic endothelial cells: Evidence for biosynthetic pathway of endothelin-1. Biochem Biophys Res Commun 162:1287-1294, 1989
20. Levin ER: Endothelins. N Engl J Med 333:356-363, 1995
21. Takahashi K, Ghatei MA, Lam HC, et al: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33:306-310 1990
22. Natarajan R, Bai W, Lanting L, et al: Effect of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-2231, 1997
23. Cha DR, Kim NH, Yoon JW, et al: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 58:104-112, 2000 (suppl 77)
24. Stevens MJ, Obrosova I, Feldman EL, et al: The sorbitolosmotic and sorbitol-redox hypotheses, in LeRoith D, Taylor SI, Olefsky JM, (eds): Diabetes Mellitus - A Fundamental and Clinical Text. ed 2. Philadelphia, PA, Lippincott Williams & Wilkins, 2000, pp 972-983
25. Tsilibary EC: Microvascular basement membranes in diabetes mellitus. J Pathol 200:537-546, 2003
26. Candido R, Allen TJ: Haemodynamics in microvascular complications in type 1 diabetes. Diabetes Metab Res Rev 18:286-304, 2002
27. Murata T, Nagai R, Ishibashi T, et al: The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40:764-769, 1997
28. Ozaki H, Yu AY, Della N, et al: Hypoxia inducible factor-1 alpha is increased in ischemic retina: Temporal and spatial correlation with VEGF expression. Invest. Ophthalmol Vis Sci 40:182-189, 1999
29. Hata Y, Nakagawa K, Ishibashi T, et al: Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 426:479-486, 1995
30. Lu M, Kuroki M, Amano S, et al: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224, 1998
31. Shalaby F, Rossant J, Yamaguchi TP, et al: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995
32. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425, 1997
33. Valabhji J, Dhanjil S, Nicolaides AN, et al: Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type I diabetic subjects and normal subjects. Metabolism 50:825-829, 2001
34. Cediel E, Vazquez-Cruz B, Navarro-Cid J, et al: Role of endothelin-1 and thromboxane A2 in renal vasocontriction induced by angiotensin II in diabetes and hypertension. Kidney Int 92:2-7, 2002 (suppl)
35. Cardillo C, Campia U, Bryant MB, et al: Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106:1783-1787, 2002